Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

Vaccine

Volumn 23, Issue 27, 2005, Pages 3493-3499

  Arribillaga, Laura ^a   Sarobe, Pablo ^a   Arina, Ainhoa ^a   Gorraiz, Marta ^a   Borrás Cuesta, Francisco ^a   Ruiz, Juan ^a   Prieto, Jesús ^a   Chen, Lieping ^b   Melero, Ignacio ^a   Lasarte, Juan José ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

4 1BB; Hepatitis C virus; Vaccination

Indexed keywords

CD137 MONOCLONAL ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; HEPATITIS C VACCINE; MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTIGENICITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOGENICITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

EID: 20944446056     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.003     Document Type: Article

References (62)

1. World-Health-Organisation Hepatitis C Wkly Epidemiol Rec 72 1997 65
2. J.L. Dienstag Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features Gastroenterology 85 2 1983 439 462
3. P. Botarelli, M.R. Brunetto, M.A. Minutello, P. Calvo, D. Unutmaz, and A.J. Weiner T-lymphocyte response to hepatitis C virus in different clinical courses of infection Gastroenterology 104 2 1993 580 587
4. C. Ferrari, A. Valli, L. Galati, A. Penna, P. Scaccaglia, and T. Giuberti T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections Hepatology 19 2 1994 286 295
5. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, and A. Liebetrau Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 6 5 2000 578 582
6. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection Hepatology 21 3 1995 632 638
7. J.J. Lasarte, M. Garcia Granero, A. Lopez, N. Casares, N. Garcia, and M.P. Civeira Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C Hepatology 28 3 1998 815 822
8. M. Aechmann, H.G. Ihlenfeldt, I. Braunschweiger, G. Giers, G. Jung, and B. Matz T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus - positive blood donors without viremia Hepatology 24 4 1996 790 795
9. H.M. Diepolder, R. Zachoval, R.M. Hoffmann, E.A. Wierenga, T. Santantonio, and M.C. Jung Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 8981 1995 1006 1007
10. H.F. Lohr, D. Schmitz, M. Arenz, S. Weyer, and G. Gerken Meyer zum Buschenfelde KH The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies J Hepatol 31 3 1999 407 415
11. + T cells with viral clearance in acute hepatitis C J Infect Dis 181 5 2000 1528 1536
12. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J Exp Med 194 10 2001 1395 1406
13. G.R. Pape, T.J. Gerlach, H.M. Diepolder, N. Gruner, M. Jung, and T. Santantonio Role of the specific T-cell response for clearance and control of hepatitis C virus J Viral Hepat 6 Suppl 1 1999 36 40
14. X.S. He, B. Rehermann, F.X. Lopez-Labrador, J. Boisvert, R. Cheung, and J. Mumm Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers Proc Natl Acad Sci USA 96 10 1999 5692 5697
15. A. Cerny, J.G. McHutchison, C. Pasquinelli, M.E. Brown, M.A. Brothers, and B. Grabscheid Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif J Clin Invest 95 2 1995 521 530
16. K. Kurokohchi, T. Akatsuka, C.D. Pendleton, A. Takamizawa, M. Nishioka, and M. Battegay Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region J Virol 70 1 1996 232 240
17. L. Arribillaga, A.L. de Cerio, P. Sarobe, N. Casares, M. Gorraiz, and A. Vales Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus Vaccine 21 3-4 2002 202 210
18. A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, and L. Romics Jr. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation J Immunol 170 11 2003 5615 5624
19. P. Sarobe, J.J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, and P. Labarga Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins J Virol 76 10 2002 5062 5070
20. P. Sarobe, J.J. Lasarte, A. Zabaleta, L. Arribillaga, A. Arina, and I. Melero Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses J Virol 77 20 2003 10862 10871
21. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 6673 1998 245 252
22. S. Oh, J.W. Hodge, J.D. Ahlers, D.S. Burke, J. Schlom, and J.A. Berzofsky Selective induction of high avidity CTL by altering the balance of signals from APC J Immunol 170 5 2003 2523 2530
23. M.V. Maus, A.K. Thomas, D.G. Leonard, D. Allman, K. Addya, and K. Schlienger Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor CD28 and 4-1BB Nat Biotechnol 20 2 2002 143 148
24. H.R. Salih, P.A. Kiener, and V. Nussler 4-1 BB ligand - just another costimulating molecule Int J Clin Pharmacol Ther 40 8 2002 348 353
25. K.E. Pollok, Y.J. Kim, Z. Zhou, J. Hurtado, K.K. Kim, and R.T. Pickard Inducible T cell antigen 4-1BB Analysis of expression and function. J Immunol 150 3 1993 771 781
26. M. Croft Co-stimulatory members of the TNFR family: keys to effective T-cell immunity Nat Rev Immunol 3 8 2003 609 620
27. R.A. Wilcox, A.I. Chapoval, K.S. Gorski, M. Otsuji, T. Shin, and D.B. Flies Cutting edge: expression of functional CD137 receptor by dendritic cells J Immunol 168 9 2002 4262 4267
28. T. Futagawa, H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, and H. Yagita Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells Int Immunol 14 3 2002 275 286
29. R.G. Goodwin, W.S. Din, T. Davis-Smith, D.M. Anderson, S.D. Gimpel, and T.A. Sato Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor Eur J Immunol 23 10 1993 2631 2641
30. K.E. Pollok, Y.J. Kim, J. Hurtado, Z. Zhou, K.K. Kim, and B.S. Kwon 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells Eur J Immunol 24 2 1994 367 374
31. I. Melero, W.W. Shuford, S.A. Newby, A. Aruffo, J.A. Ledbetter, and K.E. Hellstrom Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors Nat Med 3 6 1997 682 685
32. C. Takahashi, R.S. Mittler, and A.T. Vella Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal J Immunol 162 9 1999 5037 5040
33. D. Cooper, P. Bansal-Pakala, and M. Croft 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity Eur J Immunol 32 2 2002 521 529
34. M.A. DeBenedette, T. Wen, M.F. Bachmann, P.S. Ohashi, B.H. Barber, and K.L. Stocking Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus J Immunol 163 9 1999 4833 4841
35. J.T. Tan, J.K. Whitmire, R. Ahmed, T.C. Pearson, and C.P. Larsen 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses J Immunol 163 9 1999 4859 4868
36. E.M. Bertram, P. Lau, and T.H. Watts Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection J Immunol 168 8 2002 3777 3785
37. + T cells Trends Immunol 23 8 2002 378 380
38. L. Diehl, G.J. van Mierlo, A.T. den Boer, E. van der Voort, M. Fransen, and L. van Bostelen In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway J Immunol 168 8 2002 3755 3762
39. T. Wen, J. Bukczynski, and T.H. Watts 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function J Immunol 168 10 2002 4897 4906
40. J. Bukczynski, T. Wen, and T.H. Watts Costimulation of human CD28-T cells by 4-1BB ligand Eur J Immunol 33 2 2003 446 454
41. R.A. Wilcox, D.B. Flies, G. Zhu, A.J. Johnson, K. Tamada, and A.I. Chapoval Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors J Clin Invest 109 5 2002 651 659
42. I. Tirapu, A. Arina, G. Mazzolini, M. Duarte, C. Alfaro, and E. Feijoo Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens Int J Cancer 110 1 2004 51 60
43. F. Borras Cuesta, J. Golvano, P. Sarobe, J.J. Lasarte, I. Prieto, and A. Szabo Insights on the amino acid side-chain interactions of a synthetic T-cell determinant Biologicals 19 3 1991 187 190
44. J.J. Lasarte, P. Sarobe, A. Gullon, J. Prieto, and F. Borras Cuesta Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct Cell Immunol 141 1 1992 211 218
45. A. Franco, C. Ferrari, A. Sette, and F.V. Chisari Viral mutations TCR antagonism and escape from the immune response Curr Opin Immunol 7 4 1995 524 531
46. L.K. Borysiewicz, J.K. Hickling, S. Graham, J. Sinclair, M.P. Cranage, and G.L. Smith Human cytomegalovirus-specific cytotoxic T cells Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses J Exp Med 168 3 1988 919 931
47. A. Carmichael, X. Jin, P. Sissons, and L. Borysiewicz Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease J Exp Med 177 2 1993 249 256
48. G.M. Lauer, T.N. Nguyen, C.L. Day, G.K. Robbins, T. Flynn, and K. McGowan Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses J Virol 76 6 2002 2817 2826
49. + T cells in chronic hepatitis C virus infection J Immunol 169 6 2002 3447 3458
50. J.L. Cannons, P. Lau, B. Ghumman, M.A. DeBenedette, H. Yagita, and K. Okumura 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy J Immunol 167 3 2001 1313 1324
51. J.T. Tan, J.K. Whitmire, K. Murali-Krishna, R. Ahmed, J.D. Altman, and R.S. Mittler 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination J Immunol 164 5 2000 2320 2325
52. R.S. Mittler, T.S. Bailey, K. Klussman, M.D. Trailsmith, and M.K. Hoffmann Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy J Exp Med 190 10 1999 1535 1540
53. J. Foell, S. Strahotin, S.P. O'Neil, M.M. McCausland, C. Suwyn, and M. Haber CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice J Clin Invest 111 10 2003 1505 1518
54. Y. Sun, X. Lin, H.M. Chen, Q. Wu, S.K. Subudhi, and L. Chen Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis J Immunol 168 3 2002 1457 1465
55. + and CD28-T cells J Immunol 158 7 1997 3081 3089
56. I. Gramaglia, D. Cooper, K.T. Miner, B.S. Kwon, and M. Croft Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand Eur J Immunol 30 2 2000 392 402
57. B.R. Blazar, B.S. Kwon, A. Panoskaltsis-Mortari, K.B. Kwak, J.J. Peschon, and P.A. Taylor Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients J Immunol 166 5 2001 3174 3183
58. Y. Seko, N. Takahashi, H. Oshima, O. Shimozato, H. Akiba, and K. Takeda Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3 J Pathol 195 5 2001 593 603
59. W. Dawicki, and T.H. Watts Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo Eur J Immunol 34 3 2004 743 751
60. + T cell responses Exp Mol Med 35 6 2003 509 517
61. + T cells J Leukoc Biol 23 2003 23
62. + T cell responses Nat Immunol 3 6 2002 536 541